Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Handa

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Canadian Medical Association Journal|September 1, 1983
A large regional hospital's experience with treatment of end-stage renal diseaseS P Handa, H K Wolf
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 1982
Comparison between active and passive blood pressure surveysS P Handa, H K Wolf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1997
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsS P Handa, P S Sohi
Nephron|January 1, 1981
Urinary tract carcinoma in patients with analgesic nephropathyS P Handa, H D Tewari
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 1, 1980
Prevalence of hypertension: a screening survey in an adult populationS P Handa, S Roma, H Brewer
American Journal of Hypertension|April 1, 1995
The relationship of plasma norepinephrine levels and aortic distensibility in elderly with isolated systolic hypertensionS P Handa, J Wong, H K Wolf
Investigative Urology|November 1, 1970
The effect of uremic environment on renal concentrating and diluting mechanisms in a severely damaged nephron populationP A Morrin, S K Joynt, S P Handa, et al.
Transplantation Proceedings|August 1, 1989
Urine cytology in a case of B-cell lymphoma in a transplanted kidneyR Gupta, P Belitsky, L Stewart, et al.
Cardiovascular Drugs and Therapy|June 1, 1995
Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial GroupT D Ruddy, J M Wright, D Savard, et al.
Cardiovascular Drugs and Therapy|December 1, 1995
24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazemT D Ruddy, J M Wright, D Savard, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Canadian Medical Association Journal|September 1, 1983
A large regional hospital's experience with treatment of end-stage renal diseaseS P Handa, H K Wolf
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|July 1, 1982
Comparison between active and passive blood pressure surveysS P Handa, H K Wolf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1997
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patientsS P Handa, P S Sohi
Nephron|January 1, 1981
Urinary tract carcinoma in patients with analgesic nephropathyS P Handa, H D Tewari
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 1, 1980
Prevalence of hypertension: a screening survey in an adult populationS P Handa, S Roma, H Brewer
American Journal of Hypertension|April 1, 1995
The relationship of plasma norepinephrine levels and aortic distensibility in elderly with isolated systolic hypertensionS P Handa, J Wong, H K Wolf
Investigative Urology|November 1, 1970
The effect of uremic environment on renal concentrating and diluting mechanisms in a severely damaged nephron populationP A Morrin, S K Joynt, S P Handa, et al.
Transplantation Proceedings|August 1, 1989
Urine cytology in a case of B-cell lymphoma in a transplanted kidneyR Gupta, P Belitsky, L Stewart, et al.
Cardiovascular Drugs and Therapy|June 1, 1995
Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial GroupT D Ruddy, J M Wright, D Savard, et al.
Cardiovascular Drugs and Therapy|December 1, 1995
24 hour blood pressure control with once-daily versus twice-daily formulations of diltiazemT D Ruddy, J M Wright, D Savard, et al.
Pageof 4